Lasa Supergenics Share Price

NSE: LASA

S Cap

₹ 7.62

+₹0.05 (0.66%)

Last updated 13 Aug, 2026, 15:20 IST

Lasa Supergenics Share Price Today

As of 14 Aug 2026, Lasa Supergenics share price is ₹7.62. The stock opened at ₹7.15, compared to its previous close of ₹7.57. During today's trading session, Lasa Supergenics share price moved in the range of ₹7.15 to ₹7.75, with an average price of ₹7.45 for the day. Looking at its last 52-week, the stock has touched a low of ₹5.67 and a high of ₹14.08. On the performance front, Lasa Supergenics share price has declined by 15.79% over the last six months and is down 25.10% on a year-on-year basis.

₹7.15

0.66% up today

₹7.75

1D LOW

1D HIGH

Stock Performance

OutperformingBeat Nifty by 2.49 % in last 1 month

Lasa Supergenics Returns Calculator

If you would've invested

₹

₹1,000₹1Cr

Historical Returns

1 Year

₹3,90,769-₹1,09,231 (-21.85%)

3 Year

₹1,18,877-₹3,81,123 (-76.22%)

5 Year

₹48,784-₹4,51,216 (-90.24%)

₹6.06₹9.08

Circuit Low

Circuit High

₹5.67₹14.08

52-Week Low

52-Week High

Circuit

₹6.06

₹9.08

52-week

₹5.67

₹14.08

About Lasa Supergenics

ISIN

INE670X01014

Sector Market Cap

₹ 37.73 Cr

Lasa Supergenerics Limited is an India-based company, which is engaged in the business of manufacturing active pharmaceutical ingredients (API) bulk drugs products. The Company is engaged in the business of manufacturing, trading, producing, processing, preparing, and treating chemicals, API, pharmaceuticals, drugs, and others. It specializes in catalyst chemistry and manufactures anthelmintic/ veterinary API products with production capabilities and product categories in India. The Company's products include API products, other API products, animal feed ingredients and reagents for therapeutic use. Its API products include Fenbendazole, Toldimphos sodium, Cyromazine, Albendazole, Riclabendazole, Rafoxanide, Ornidazole, 2,6-Diiodo-4-Nitrophenol, Ricobendazole, Oxfendazole, Closantel Base, Closantel sodium, Nitroxynil, Halquinol, and Oxyclozanide. The Company's manufacturing facility is located in Chiplun, Maharashtra.

Lasa Supergenics Financial Highlights

Revenue: Lasa Supergenics reported revenue of ₹25.34 crore in FY26 vs ₹147.46 crore in FY25. It showed a decrease of 82.82% on a yearly basis.
Operating Profit: Lasa Supergenics reported an operating loss of ₹34.61 crore in FY26 vs ₹19.38 crore in FY25. It showed a decrease of 78.59% on a year-on-year basis.
Net Profit: Lasa Supergenics reported a net loss of ₹34.09 crore in FY26 vs ₹14.76 crore in FY25. It showed a decrease of 130.96% on a yearly basis.

Lasa Supergenics Quarterly Result Highlights

Lasa Supergenics reported revenue of ₹0.09 crore in Mar 2026, compared with ₹2.22 crore in Dec 2025, representing a decrease of 104.05% on a quarter-on-quarter (QoQ) basis.
Lasa Supergenics reported an operating loss of ₹3.98 crore in Mar 2026, compared with ₹2.41 crore in Dec 2025, representing a decrease of 65.15% on a quarter-on-quarter (QoQ) basis.
Lasa Supergenics reported a loss of ₹4.16 crore in Mar 2026, compared with ₹2.55 crore in Dec 2025, reflecting a decrease of 63.14% on a QoQ basis.
The earnings per share (EPS) of Lasa Supergenics stood at ₹2.95 during Mar 2026.

Know more

Promoters

53.65%

FII

0.00%

Other DII

0.00%

Retail and other

46.35%

Mutual funds

0.00%

Foreign institutions - FII

FII shareholding by period
Jun 2025	0.00%
Sep 2025	0.00%
Dec 2025	0.00%
Mar 2026	0.00%

Mkt Cap Cr

37.73

P/E

-1.10

P/B

0.75

ROE

-26.30%

D/E

0.20

ROCE

-22.21%

Div. Yield

0.00%

EPS(TTM)

-6.80

Turnover

0.51

EV/EBITDA

-1.67

Net Margin

0.00%

Op. Margin

0.00%

ROA

-51.43%

Quick Ratio

0.00

Curr. Ratio

1.49

Mkt Cap Cr

37.73

P/E

-1.10

P/B

0.75

ROE

-26.30%

D/E

0.20

ROCE

-22.21%

Div. Yield

0.00%

EPS(TTM)

-6.80

Turnover

0.51

EV/EBITDA

-1.67

Net Margin

0.00%

Op. Margin

0.00%

ROA

-51.43%

Quick Ratio

0.00

Curr. Ratio

1.49

Based on fundamentals, this stock's

Performance

Excellent

Lasa Supergeneri outperforming all market indices

Valuation

Overvalued

Lasa Supergeneri appears overvalued compared to its peers

Peer Comparison

Peer comparison — key ratios
Name	Mkt Cap Cr	P/E	P/B	ROE	D/E	ROCE	Book Value	Div. Yield	Turnover	EPS(TTM)
Sun Pharmaceutical Industries	4,64,271.00	38.32	5.56	13.74%	0.61	17.33%	93.24	0.83%	0.48	10.90
Divis Laboratories	2,26,843.00	77.55	13.53	15.32%	0.00	19.56%	629.49	0.35%	0.55	98.19
Torrent Pharmaceuticals	1,86,000.00	86.27	22.12	25.49%	1.69	13.85%	222.76	0.69%	0.49	58.70
Zydus Lifesciences	1,20,099.00	26.15	4.43	18.59%	0.31	17.35%	237.30	0.08%	0.33	35.38
Cipla	1,18,027.00	35.18	3.43	11.27%	0.00	14.95%	423.36	0.89%	0.45	43.52
Lupin	1,03,549.00	18.65	4.61	23.76%	0.04	24.88%	659.05	0.79%	0.57	129.18
Mankind Pharma	1,00,137.00	48.43	6.14	11.74%	0.34	13.13%	397.02	0.04%	0.44	49.37
Dr. Reddy's Laboratories	1,00,073.00	31.44	2.63	11.07%	0.18	12.54%	377.96	0.67%	0.41	38.68
Laurus Labs	99,474.20	91.23	18.77	16.77%	0.40	16.14%	97.20	0.11%	0.67	13.72
Aurobindo Pharma	96,700.60	26.06	2.55	9.25%	0.19	11.76%	391.14	0.24%	0.38	41.58

Lasa Supergenics Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Revenue	₹142.45	₹104.34	₹129.57	₹137.13
Other Income	₹5.01	₹0.10	₹1.80	₹0.27
Total Revenue	₹147.46	₹104.43	₹131.37	₹137.40
Total Expenses	₹151.17	₹114.77	₹153.74	₹135.68
Profit Before Tax	-₹19.38	-₹19.11	-₹42.27	-₹6.14
Tax	-₹4.63	₹2.62	-₹3.64	-₹0.81
Profit After Tax	-₹14.76	-₹21.73	-₹38.62	-₹5.33
EPS - Basic	-₹2.95	-₹4.34	-₹7.71	-₹1.06
EPS - Diluted	-₹2.95	-₹4.34	-₹7.71	-₹1.06

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Profit before tax	-₹19.38	-₹19.11	-₹22.37	₹1.72
Income before WC changes	₹9.16	-₹10.69	-₹26.44	₹8.22
Change in Assets	-₹1.71	₹6.82	₹12.24	₹5.58
Change in Liabilities	-₹10.27	₹6.01	-₹3.06	-₹2.00
Change in WC	-₹11.98	₹12.83	₹9.18	₹3.59
Cash flow from Operations	-₹2.82	₹2.14	-₹17.30	₹9.21
Cash flow from Investing	₹8.15	-₹0.40	₹11.19	-₹2.91
Cash flow from Financing	-₹5.66	-₹1.93	-₹4.16	-₹0.04
Total Cash Flow	-₹0.33	-₹0.19	-₹10.27	₹6.26
Cash (Start of the year)	₹0.61	₹0.80	₹11.07	₹4.81
Cash (End of the year)	₹0.28	₹0.61	₹0.80	₹11.07

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Non-Current Assets	₹69.02	₹112.98	₹124.63	₹142.87
Current Assets	₹32.51	₹37.89	₹39.22	₹66.30
Total Assets	₹101.53	₹150.87	₹163.85	₹209.17
Current Liabilities	₹17.15	₹48.87	₹42.73	₹44.75
Net Current Asset	₹15.36	-₹10.98	-₹3.51	₹21.55
Non-Current Liabilities	₹0.66	₹5.32	₹2.84	₹6.54
Equity Capital	₹83.71	₹96.68	₹118.29	₹157.88
Total Equity & Liabilities	₹101.53	₹150.87	₹163.85	₹209.17